FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/095990 [Registered on: 13/10/2025] Trial Registered Prospectively
Last Modified On: 11/10/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Medical Device
Screening 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Comparing two methods to assess the level of sedation in patients to find the more accurate technique.”  
Scientific Title of Study   A Study to compare Bispectral index objective sedation scale versus Richmond agitation sedation scale (RAAS subjective scale) in critically ill mechanically ventilated patients for clinical evaluation 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sathya Narayanan K  
Designation  DM Critical care medicine , senior resident  
Affiliation  Bangalore Medical College and Research Institute, Bangalore  
Address  DEPARTMENT OF CRITICAL CARE MEDICINE Bangalore

Bangalore
KARNATAKA
560022
India 
Phone  09597447444  
Fax    
Email  sathyavaan4444@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr VIJAYA KUMAR  
Designation  Professor and Head , Department of critical care medicine  
Affiliation  Bangalore Medical College and Research Institute, Bangalore - BANGALORE  
Address  Department of Critical Care Medicine , 5th floor , Trauma and emergency care centre Bangalore Medical College Bangalore

Bangalore
KARNATAKA
560022
India 
Phone  09597447444  
Fax    
Email  viji2751977@gmail.com   
 
Details of Contact Person
Public Query
 
Name  Dr Sathya Narayanan K  
Designation  DM Critical care medicine , senior resident  
Affiliation  Bangalore Medical College and Research Institute, Bangalore  
Address  DEPARTMENT OF CRITICAL CARE MEDICINE Bangalore

Bangalore
KARNATAKA
560022
India 
Phone  09597447444  
Fax    
Email  sathyavaan4444@gmail.com  
 
Source of Monetary or Material Support  
Bangalore medical college & Research institute, Karnataka ,India pin code - 560022  
 
Primary Sponsor  
Name  Department of Critical Care Medicine 
Address  5th floor , Trauma and emergency care centre , Bangalore Medical College , BMCRI , Bangalore , Karnataka, India - 560022  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrSathya NarayananK  Bangalore Medical College & Research Institute   Department of Critical Care Medicine , 5th floor , Trauma and emergency care centre , Bangalore Medical College, Fort, K.R. Road, Bangalore, Karnataka, India · 560 002 · Krishna Rajendra Road Bangalore KARNATAKA
Bangalore
KARNATAKA 
09597447444

sathyavaan4444@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committe Bangalore Medical College & Research Institute e,  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J17||Pneumonia in diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  BIS  The BIS electrode placement above the bridge of the nose, over the temple area and between the corner of the eye and the hairline will be attached continuously in all patients included in the study for 3 days.  
Intervention  RASS  The RASS score will be read every 4th hourly while in corresponding RASS will be recorded. All the outcome parameters will be recorded for the duration of 24 hours 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Age 18 to 65 years and Mechanically ventilated for more than 48 hours.
2.Patients/ Parents/ Caregivers who are willing to give informed consent
3.Patients with renal and hepatic disorder for subgroup analysis.
 
 
ExclusionCriteria 
Details  1. Head injuries
2. Required Deep (Barbiturate Coma) Sedation for Status Epilepticus.
3.Patients known to have any focal brain disease or abnormal electrical brain activities such as epilepsy .
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Sensitivity , Specificity, Positive predictive & negative predictive values of BIS and clinical sedation scales.
Correation between BIS and RASS.
 
every 4 hourly till extubation
 
 
Secondary Outcome  
Outcome  TimePoints 
Whether BIS monitoring can reduce sedative dose requirements while preventing undersedation events.  total volume in ml of drug infused in the 24 h study period;.  
 
Target Sample Size   Total Sample Size="46"
Sample Size from India="46" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [sathyavaan4444@gmail.com].

  6. For how long will this data be available start date provided 15-10-2025 and end date provided 25-12-2027?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Delirium being an independent risk factor for ICU mortality can result in over sedation, increased duration of mechanical ventilation and increased length of ICU stay.
Sedatives are commonly administered to ICU patients to control agitation. Sedatives must be titrated to attain either light sedation (i.e., the patient is arousable and able to consciously obey simple commands) or profound sedation (i.e., the patient is unresponsive to noxious stimuli), contingent upon the patient’s clinical status and expected ICU length.
Nonetheless, tools such as the Richmond Agitation–Sedation Scale (RASS) require subjective evaluation, potentially leading to measurement variability and subsequent clinical actions. The bispectral index (BIS) is an objective measure for evaluating levels of awareness, frequently employed as an anaesthetic tool, with its use also expanding to the intensive care unit (ICU). The existing published findings are insufficient to warrant the extensive use of the BIS in patients with organophosphorus poisoning presenting with delirium 

 


 
Close